Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.805 USD | -1.93% | -2.42% | +81.75% |
05-03 | Wedbush Adjusts Geron's Price Target to $7 From $6, Keeps Outperform Rating | MT |
05-02 | Geron Shares Decline After Q1 Loss Widens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+81.75% | 2.3B | |
+2.74% | 108B | |
+11.04% | 104B | |
+1.51% | 22.33B | |
-11.89% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.86% | 17.64B | |
+5.25% | 14.05B | |
+35.24% | 12.51B |
- Stock Market
- Equities
- GERN Stock
- News Geron Corporation
- Geron's Imetelstat's Safety a Key Focus for FDA's Oncology Drugs Advisory Committee Meeting